MJMuzhou Jiang

Muzhou Jiang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Muzhou Jiang has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Junjun Ni

    Key Laboratory of Molecular Medicine and Biotherapy, Department of Biology, School of Life Science Beijing Institute of Technology Beijing China

    2 shared publications
  • Zhou Wu

    Department of Aging Science and Pharmacology, Faculty of Dental Science Kyushu University Fukuoka Japan

    2 shared publications
  • Fan Zeng

    The Brain Cognition and Brain Disease Institute, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences

    1 shared publication
  • Gregory Hook

    American Life Science Pharmaceuticals La Jolla CA USA

    1 shared publication
  • Guangyu Zhang

    Department of Periodontology School of Stomatology China Medical University Shenyang Liaoning Province China

    1 shared publication
  • Haruhiko Kashiwazaki

    Section of Geriatric Dentistry and Perioperative Medicine in Dentistry, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Fukuoka 812-8582, Japan

    1 shared publication

Latest Publications

  • Role of PG0192 and PG0193 in the modulation of pro‐inflammatory cytokines in macrophages in response to Porphyromonas gingivalis

    by Hongyan Wang, Wenying Peng, Guangyu Zhang, Muzhou Jiang, Jian Zhao, Xue Zhao, Yaping Pan, Li Lin

    Porphyromonas gingivalis is the main pathogen of chronic periodontitis. However, the specific mechanisms through which P. gingivalis induces immune and inflammatory responses in periodontitis have not been completely elucidated. In this study, we investigated the effects of the P. gingivalis outer membrane protein OmpH (encoded by PG0192 and PG0193) on interleukin‐6 (IL‐6) and tumor necrosis factor‐α (TNF‐α) expression in macrophages to assess the pro‐inflammatory cytokine responses. A PG0192‐PG0193 deletion mutant strain and a com△PG0192‐0193 strain were constructed. Furthermore, rOmpH‐1 and rOmpH‐2 encoded by PG0192 and PG0193, respectively, were cloned, expressed, and purified for subsequent experiments. Notably, the expression of IL‐6 and TNF‐α at mRNA and protein levels was downregulated upon treatment of macrophages with the PG0192‐PG0193 deletion mutant strain, whereas treatment of macrophages with P. gingivalis W83 co‐incubated with rOmpH‐1 or rOmpH‐2 upregulated IL‐6 and TNF‐α mRNA levels. The addition of C5aR antagonist blocked this induction. Overall, our findings provided important insights into the roles of PG0192 and PG0193 for promoting IL‐6 and TNF‐α expression in macrophages exposed to P. gingivalis and revealed the involvement of C5aR in the pro‐inflammatory response.


  • Cathepsin B inhibition blocks neurite outgrowth in cultured neurons by regulating lysosomal trafficking and remodeling

    by Muzhou Jiang, Jie Meng, Fan Zeng, Hong Qing, Gregory Hook, Vivian Hook, Zhou Wu, Junjun Ni

    Lysosomes are known to mediate neurite outgrowth in neurons. However, the principal lysosomal molecule controlling that outgrowth is unclear. We studied primary mouse neurons in vitro and found that they naturally develop neurite outgrowths over time and as they did so the lysosomal cysteine protease cathepsin B (CTSB) mRNA levels dramatically increased. Surprisingly, we found that treating those neurons with CA‐074Me, which inhibits CTSB, prevented neurites. As that compound also inhibits another protease, we evaluated a N2a neuronal cell line in which the CTSB gene was deleted (CTSB KO) using CRISPR technology and induced their neurite outgrowth by treatment with retinoic acid. We found that CTSB KO N2a cells failed to produce neurite outgrowths but the wild‐type (WT) did. CA‐074Me is a cell permeable prodrug of CA‐074, which is cell impermeable and a specific CTSB inhibitor. Neurite outgrowth was and was not suppressed in WT N2a cells treated with CA‐074Me and CA‐074, respectively. Lysosome‐associated membrane glycoprotein2 (LAMP2)‐positive lysosomes traffic to the plasma cell membrane in WT but not in CTSB KO N2a cells. Interestingly, no obvious differences between WT and CTSB KO N2a cells were found in neurite outgrowth regulatory proteins, PI3K/AKT, ERK/MAPK, cJUN and CREB. These findings show that intracellular CTSB controls neurite outgrowth and that it does so through regulation of lysosomal trafficking and remodeling in neurons. This adds valuable information regarding the physiological function of CTSB in neural development.